DSIJ Mindshare

Despite the sharp decline, the regulatory setback isn't as severe as it seems—the letter only raises compliance concerns without halting operations or triggering an import alert.

Regulatory changes, such as the US Biosecure Act, may accelerate growth for CDMO businesses. However, uncertainties remain, especially if Donald Trump returns to power. Trump has criticized India on trade issues, including pharmaceutical tariffs, which could impact domestic pharma strategies.

The company has a ROCE of 19.4 per cent and a ROE of 19.1 per cent.

On Monday, the Sensex fell by 175 points to close at 59,288.35, while the Nifty 50 dropped by 73 points to close at 17,392.70

On Friday, investors piled up the metal and IT shares, coupled with some major Sensex stocks like Reliance Industries, HDFC twins, Sun Pharma, and Bajaj Finance. The benchmark indices ended the trading session near the day's high level, closing the week on a green note.